Genmab Revenue 2019-2024 | GMAB

Genmab revenue for the twelve months ending September 30, 2024 was $2.874B, a 16.87% increase year-over-year.

  • Genmab annual revenue for 2023 was $2.392B, a 15.74% increase from 2022.
  • Genmab annual revenue for 2022 was $2.067B, a 53.14% increase from 2021.
  • Genmab annual revenue for 2021 was $1.349B, a 12.88% decline from 2020.

Genmab Revenue 2019-2024 | GMAB

  • Genmab annual revenue for 2023 was $2.392B, a 15.74% increase from 2022.
  • Genmab annual revenue for 2022 was $2.067B, a 53.14% increase from 2021.
  • Genmab annual revenue for 2021 was $1.349B, a 12.88% decline from 2020.